First regulatory authorization of a CRISPR-based gene-editing therapy in Canada TORONTO, ON – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced Health Canada has granted Marketing Authorization for PrCASGEVY® (exagamglogene autotemcel), an autologous genome… Read More
Mintz is pleased to be the exclusive legal partner of The Engine’s 2024 “Tough Tech Week” summit taking place October 7-11 in Boston. The Engine is an accelerator program started… Read More
Nine Faculty of Medicine staff members are among this year’s recipients of the UBC President’s Awards for Staff. The awards, which include the President’s Service Awards for Excellence and President’s Staff Awards, are… Read More
Omicron KP.2 variant adapted vaccine COMIRNATY® is now authorized in Canada for individuals 6 months of age and older. It is expected to be available in Canada in the coming weeks…. Read More
GlycoNet investigators have developed a new diagnostic test that will advance organ transplantation and enable more transplants across blood type barriers, saving more lives. The ABO blood group system is… Read More
